Stocks and Investing
Stocks and Investing
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sarah James Reiterated (THC) at Buy and Held Target at $112 on, Jul 10th, 2024
Sarah James of Cantor Fitzgerald, Reiterated "Tenet Healthcare Corporation" (THC) at Buy and Held Target at $112 on, Jul 10th, 2024.
Sarah has made no other calls on THC in the last 4 months.
There are 10 other peers that have a rating on THC. Out of the 10 peers that are also analyzing THC, 1 agrees with Sarah's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $122 on, Wednesday, May 1st, 2024
These are the ratings of the 9 analyists that currently disagree with Sarah
- Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $155 on, Friday, June 28th, 2024
- Lisa Gill of "JP Morgan" Maintained at Buy with Increased Target to $140 on, Thursday, May 30th, 2024
- Michael Ha of "Baird" Initiated at Buy and Held Target at $153 on, Thursday, May 30th, 2024
- A.J. Rice of "UBS" Maintained at Strong Buy with Increased Target to $150 on, Wednesday, May 1st, 2024
- Ann Hynes of "Mizuho" Reiterated at Strong Buy with Increased Target to $130 on, Wednesday, May 1st, 2024
- Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $136 on, Wednesday, May 1st, 2024
- David Macdonald of "Truist Securities" Reiterated at Strong Buy with Increased Target to $130 on, Wednesday, May 1st, 2024
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, March 28th, 2024
- Justin Lake of "Wolfe Research" Upgraded from Hold to Buy and Held Target at $122 on, Wednesday, March 27th, 2024
Contributing Sources